Vir Biotechnology Appoints Jeff Calcagno M.D. as Executive Vice President and Chief Business Officer

Vir Biotechnology Appoints Jeff Calcagno M.D. as Executive Vice President and Chief Business Officer

SAN FRANCISCO, May 15, 2023 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Jeff Calcagno, M.D., as Executive Vice President and Chief Business Officer. D… [read more]

Similar Posts